How to Get Ozempic or Wegovy Covered by Insurance in 2026

Getting Ozempic or Wegovy covered by insurance is one of the biggest hurdles patients face. The sticker price ($1,000–$1,400/month) is out of reach for most people without coverage — but the coverage landscape is more navigable than many realize. Here’s a practical guide to every option available in 2026.

The Coverage Landscape: Why It’s Complicated

Insurance coverage for GLP-1 medications varies dramatically depending on your plan type, employer, diagnosis, and state. The key split is between two indications:

• Type 2 diabetes: Ozempic is FDA-approved for T2D and is covered by most commercial plans and Medicare Part D for this indication. Coverage is generally much easier to obtain.
• Weight loss/obesity: Wegovy is FDA-approved for chronic weight management, but coverage is far more inconsistent. Many plans exclude it entirely, and Medicare historically hasn’t covered weight loss drugs (though this is changing).

How to Get Ozempic Covered by Insurance (Step by Step)

Step 1: Check Your Plan’s Formulary

Log into your insurance portal and search your plan’s drug formulary (covered medication list) for “semaglutide,” “Ozempic,” or “Wegovy.” Look at:

• Which tier the drug is on (Tier 3–5 typically means high cost-share)
• Whether prior authorization is required (it almost certainly is)
• Whether quantity limits apply
• Whether it’s excluded entirely

Step 2: Get the Right Diagnosis Code

Coverage often hinges on the diagnosis code your doctor submits. Relevant codes include:

• E11.x — Type 2 diabetes mellitus (strongest for Ozempic coverage)
• E66.x — Obesity (required for Wegovy coverage where it’s covered)
• E11.65 — T2DM with hyperglycemia (often used)
• Z68.x — BMI codes (supporting documentation for obesity claims)

Your prescriber handles these codes — you don’t submit them — but you can ask your doctor which code they’re using and ensure your chart documentation supports it.

Step 3: Navigate Prior Authorization

Prior authorization (PA) is almost universal for GLP-1 medications. Your prescriber’s office typically submits the PA on your behalf. To improve approval odds:

• Ensure your chart has documented BMI ≥30 (or ≥27 with a weight-related comorbidity like hypertension, high cholesterol, or sleep apnea)
• Document that you’ve tried and failed other weight loss interventions (diet programs, other medications)
• Include any relevant comorbidities: T2D, cardiovascular disease, PCOS, sleep apnea
• Ask your prescriber specifically if they have a PA specialist or use a service that manages GLP-1 authorizations

Step 4: Appeal If Denied

A first denial is not the end. Most insurance denials for GLP-1s are overturned on appeal when properly documented. Steps for appeal:

• Request the specific reason for denial in writing
• Have your doctor write a letter of medical necessity addressing the denial reason specifically
• Submit clinical evidence (STEP trial data, AHA/ADA guidelines supporting treatment)
• If internal appeal fails, request an external independent review
• Many states require insurers to cover obesity treatment — check your state’s insurance mandate laws

Medicare Coverage for Ozempic and Wegovy

Medicare Part D covers Ozempic for type 2 diabetes. Coverage for Wegovy for weight loss has historically been excluded under Medicare, but the Treat and Reduce Obesity Act (TROA) — which passed as part of broader legislation — opened the door to coverage for patients with obesity-related cardiovascular disease starting in 2026.

Specifically, Medicare Part D can now cover Wegovy for patients who:

• Have established cardiovascular disease (prior heart attack, stroke, etc.)
• Have a BMI ≥27

Pure weight loss without cardiovascular disease remains an uphill battle for Medicare coverage. This is evolving — check Medicare.gov or your Part D plan for the most current formulary.

Manufacturer Savings Programs

Novo Nordisk Patient Assistance / Savings Cards

• Ozempic Savings Card: Eligible commercially insured patients may pay as little as $25/month. Income and insurance eligibility requirements apply. Not available for Medicare/Medicaid patients.
• Wegovy Savings Card: Similar structure — commercially insured patients may pay $0 for the first month and reduced cost-share ongoing.
• Patient Assistance Program (PAP): For uninsured or underinsured patients meeting income criteria (generally ≤400% of federal poverty level), Novo Nordisk may provide medication free or at very low cost.

Find these at NovoNordiskHCP.com or ask your pharmacist/prescriber about current programs.

Alternatives When Insurance Won’t Cover It

Option	Monthly Cost	What It Involves
Compounded semaglutide (telehealth)	$150–$350	Same active ingredient, compounded by licensed pharmacy; requires prescription
GoodRx / discount cards	$800–$950	Significant discount off retail but still expensive; not combinable with insurance
Manufacturer PAP	$0–$99	Income-based program for qualifying uninsured patients
Rybelsus (oral semaglutide)	$800–$900 retail; better coverage	Pill form for T2D; lower dose than Wegovy; may have better formulary placement
Savings card programs	$25–$150 (insured)	Must have commercial insurance; not for government plans

For most patients without insurance coverage, compounded semaglutide through a telehealth platform is currently the most accessible path to treatment at $150–$350/month — a fraction of the brand price.

Frequently Asked Questions

Does insurance cover Ozempic for weight loss?

Generally, no — not directly. Ozempic is FDA-approved for type 2 diabetes, not weight loss. If you have T2D, coverage is usually available. For weight loss without T2D, Wegovy (also semaglutide) is the approved product, but coverage varies widely by plan. Many employers specifically exclude weight loss drugs.

How do I get Wegovy covered by insurance?

Check your plan’s formulary first. If covered, you’ll need prior authorization with documented BMI ≥30 (or ≥27 with comorbidity) and evidence that other interventions have been tried. Your prescriber’s office manages the PA process — ask them specifically about their process for GLP-1 medications.

What if my insurance denied Ozempic or Wegovy?

Appeal. Many denials are overturned with proper medical necessity documentation. Your doctor should write a letter addressing the specific denial reason, supported by clinical evidence. If the internal appeal fails, you can request an external independent review. If insurance ultimately won’t cover it, compounded semaglutide through a telehealth platform is currently the most cost-accessible alternative.